title: [Future therapies for metabolic bone diseases. New concepts and targets].
authors.affiliation: Institut für Pharmazeutische Chemie Marie-Curie-Str. 9 60439 Frankfurt. Schubert-Zsilavecz@pharmchem.uni-frankfurt.de
authors.forename: K
authors.initials: K
authors.lastname: Nemec
authors.forename: M
authors.initials: M
authors.lastname: Schubert-Zsilavecz
mesh_terms: D001851:Bone Diseases, Metabolic / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D006023:Glycoproteins / Q000235:genetics / Q000502:physiology*; D006801:Humans; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics / Q000502:physiology*; D018124:Receptors, Tumor Necrosis Factor
chemical_list: D006023:Glycoproteins; D053244:Osteoprotegerin; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human